• No results found

Multiple Myeloma

Multiple myeloma

Multiple myeloma

... "Multiple Myeloma; Neurologic Illustrator & Photoshop, of Left Lateral Ventricle Involvement," Slide Graphic, Adobe 6"x9" MULTIPLE MYELOMA Mechanism of Bone Destruction White Blood Endoc[r] ...

30

Bone Marrow Morphology in Multiple Myeloma.

Bone Marrow Morphology in Multiple Myeloma.

... Multiple myeloma is a clonal plasma cell disorder that varies widely in its clinical course ranging from relatively indolent forms to frankly aggressive neoplasia [1] ...of myeloma was put forth by ...

87

Multiple Myeloma Survival in A Rural Population

Multiple Myeloma Survival in A Rural Population

... of multiple myeloma ...that multiple myeloma patients who resided at a rural area at the time of diagnosis had shorter survival compared to their urban ...of multiple challenges that ...

7

Multiple myeloma cancer stem cells

Multiple myeloma cancer stem cells

... Multiple myeloma (MM) is a hematologic cancer characterized by proliferation of clonal plasma cells in the bone marrow (BM) resulting in the secretion of monoclonal immunoglobulins [1, ...

12

Cytoplasmic immunoglobulin content in multiple myeloma

Cytoplasmic immunoglobulin content in multiple myeloma

... with multiple myeloma were subjected to flow cytometric analysis of DNA and cytoplasmic immunoglobulin (CIg) content using propidium iodide and direct immunofluorescence ...nonsecretory myeloma, ...

6

PROTEASOME INHIBITORS FOR USE IN MULTIPLE MYELOMA

PROTEASOME INHIBITORS FOR USE IN MULTIPLE MYELOMA

... in multiple myeloma patients who have been refractory to carfilzomib treatment 49 ...cancer, myeloma, lymphoma and multiple myeloma 50 and in advanced malignancies like solid tumors, ...

10

Repurposing Dichloroacetate for the Treatment of  Multiple Myeloma

Repurposing Dichloroacetate for the Treatment of Multiple Myeloma

... Lactate dehydrogenase A (LDHA) catalyses the conversion of pyruvate and NADH to lactate, which is the final step of the glycolysis pathway. Many malignant tumours expressed higher LDHA levels compared to normal tissues ...

237

Role of PET CT in Multiple Myeloma

Role of PET CT in Multiple Myeloma

... for multiple myeloma (MM) has increased rates of complete response (CR), a gain which has resulted in extended progression- free survival (PFS) and overall survival ...

122

Multiple Myeloma Update

Multiple Myeloma Update

... ultiple myeloma (MM) is characterized by the presence of abnormal plasma cells (myeloma cells) that accumulate into the bone ...for multiple myeloma was put forth by Brian ...and ...

6

Multiple Myeloma associated Bone Disease

Multiple Myeloma associated Bone Disease

... of multiple myeloma, being present in about 80% of patients with newly diagnosed MM, and in more during the disease ...The myeloma associated bone disease (MBD) severely affects the morbidity and ...

24

Multiple myeloma associated with IgA lambda gammopathy and multiple myeloma oncogene 1 in a Yorkshire terrier

Multiple myeloma associated with IgA lambda gammopathy and multiple myeloma oncogene 1 in a Yorkshire terrier

... Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Rich- ardson P, Landgren O, Bruno Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Za- ...

6

RENAL DISEASE IN MULTIPLE MYELOMA

RENAL DISEASE IN MULTIPLE MYELOMA

... disease during the monitored period. While evaluating the presence of risk factors in these patients and of the infectious complications they developed, as well as the chemotherapy scheme applied, we noticed the ...

5

MULTIPLE MYELOMA is an incurable hematologic

MULTIPLE MYELOMA is an incurable hematologic

... advanced multiple myeloma (stage III with at least one lytic lesion), intravenous (IV) pamidronate (90 mg ev- ery 4 weeks for nine cycles) in addition to anti- myeloma therapy significantly reduced ...

5

Spotlight on ixazomib: potential in the treatment of multiple myeloma

Spotlight on ixazomib: potential in the treatment of multiple myeloma

... with multiple myeloma, the development of drug resistance, peripheral neuropathy, and pharmacokinetic limitations continue to pose major challenges when using these ...

10

Immunosurveillance and therapy of multiple myeloma are CD226 dependent

Immunosurveillance and therapy of multiple myeloma are CD226 dependent

... Multiple myeloma (MM) is the second most common hematolog- ical malignancy in the world (1). Despite recent progress in new therapeutic options, this disease remains incurable, with a median survival not ...

14

A Case of Diffuse Pulmonary Calcification with Multiple Myeloma

A Case of Diffuse Pulmonary Calcification with Multiple Myeloma

... Multiple myeloma (MM) is the most common primary bone tumors in adults. Currently, the leading method to evaluate bone involvement in MM is plain film radiography [1,2]. Occasionally bone scintigraphy is ...

5

Multiple myeloma and physical activity: a scoping review

Multiple myeloma and physical activity: a scoping review

... of multiple myeloma, nine papers were identified in the treatment of multiple myeloma and two on smouldering multiple ...surrounding multiple myeloma and physical activity ...

10

Thalidomide and its analogues in the treatment of Multiple Myeloma

Thalidomide and its analogues in the treatment of Multiple Myeloma

... with multiple myeloma despite prior use of lenalidomide ...refractory multiple mye- loma including lenalidomide refractory patients show 59% partial response including 2 patients achieving complete ...

8

Bendamustine in patients with relapsed or refractory multiple myeloma

Bendamustine in patients with relapsed or refractory multiple myeloma

... refractory multiple myeloma in particular because of its low toxicity either as single agent or in ...advanced multiple myeloma, showing that bendamustine is an effective agent in this treat- ...

7

Prevention Of Skeletal Related Events In Multiple Myeloma: Focus On The RANK-L Pathway In The Treatment Of Multiple Myeloma

<p>Prevention Of Skeletal Related Events In Multiple Myeloma: Focus On The RANK-L Pathway In The Treatment Of Multiple Myeloma</p>

... with multiple myeloma (MM) have osteolytic bone lesions which increase the risk of skeletal-related events ...in myeloma bone disease by impairing the balance between osteoclastogenesis and ...of ...

12

Show all 10000 documents...

Related subjects